CYP1B1 rs1056836: Understanding This Genetic Variant

What each genotype means

What is rs1056836?

The rs1056836 variant is a specific change in the DNA sequence of the CYP1B1 gene. In scientific literature, this variant is often referred to by its amino acid change, historically known as Val432Leu, and more recently as p.Asn453Ser. A single nucleotide polymorphism (SNP) like this represents a variation at a single position in the DNA building blocks. This specific variant sits within the coding region of the gene, meaning it has the potential to change the structure of the protein produced by the body. Researchers track these variations to understand how subtle differences in our genetic code might influence biological processes or health outcomes over a lifetime.

The Role of the CYP1B1 Gene

The CYP1B1 gene provides instructions for making an enzyme that belongs to the cytochrome P450 family. These enzymes are primarily responsible for metabolizing various substances, including drugs and endogenous compounds like hormones. Specifically, the CYP1B1 enzyme plays a role in the metabolism of estrogens, converting them into different forms that can have varying biological effects. Because of its involvement in hormone processing and the activation of certain environmental toxins, researchers have long hypothesized that variations in this gene could influence how the body handles these substances, potentially impacting the risk of developing hormone-related conditions or cancers.

Research and Evidence Strength

The evidence linking rs1056836 to health outcomes is considered limited and often inconsistent across different studies. While some research has suggested that certain genotypes may be associated with a decreased risk of prostate or pancreatic cancer, other studies have found no significant association or have observed conflicting results in different ethnic groups. For instance, some investigations have explored whether this variant influences telomere length or interacts with other genetic factors to modify cancer risk. Because these findings are often based on observational case-control studies, they do not prove that the variant directly causes cancer. The scientific community views these associations as preliminary, and they are not currently used for clinical risk prediction.

Population Frequency

The frequency of the rs1056836 variant varies significantly depending on ancestral background. Data from large-scale population studies show that the distribution of the C and G alleles differs between groups, which is a common observation for many genetic variants. Because of this variability, a genotype that is considered common in one population may be relatively rare in another. Understanding these population-specific frequencies is essential for researchers when they design studies to ensure that findings are not skewed by the genetic background of the participants. It also highlights why results from one study population cannot always be generalized to the entire human population.

Interpreting Genetic Information

It is important to understand that having a specific genotype for rs1056836 does not determine your health destiny. Genetic associations are statistical observations made across large groups of people, not individual medical predictions. Many factors, including environment, lifestyle, and the complex interplay of thousands of other genes, contribute to health outcomes. If you have received information about this variant through genetic testing, it is best to view it as a small piece of a much larger puzzle. This information is not a diagnostic tool and should not be used to make medical decisions. Always consult with a qualified healthcare professional or a genetic counselor to discuss what genetic findings mean in the context of your personal and family health history.

Frequently asked questions

Sources & further reading

Related variants in CYP1B1